TargetMol

Florilglutamic acid (18F)

Product Code:
 
TAR-T31803
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31803-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31803-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Florilglutamic acid (18F) is a bioactive chemical.
CAS:
1196963-74-2
Molecular Weight:
206.2
Purity:
0.98
SMILES:
[C@@H](C[C@@H](C(O)=O)N)(CCC[18F])C(O)=O

References

Dong Y, Wei Y, Chen G, Huang Y, Song P, Liu S, Zheng J, Cheng M, Yuan S. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [(18)F]Alfatide versus [(18)F]FDG. Mol Imaging Biol. 2018 Jun 4. doi: 10.1007/s11307-018-1216-9. [Epub ahead of print] PubMed PMID: 29869060. Ishiwata K, Ebinuma R, Watanabe C, Hayashi K, Toyohara J. Reliable radiosynthesis of 4-[(10)B]borono-2-[(18)F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis. Ann Nucl Med. 2018 Jun 5. doi: 10.1007/s12149-018-1268-6. [Epub ahead of print] PubMed PMID: 29869193. J?rgensen JT, Norregaard K, Sim?n Mart?n M, Oddershede LB, Kjaer A. Non-invasive Early Response Monitoring of Nanoparticle-assisted Photothermal Cancer Therapy Using (18)F-FDG, (18)F-FLT, and (18)F-FET PET/CT Imaging. Nanotheranostics. 2018 Apr 27;2(3):201-210. doi: 10.7150/ntno.24478. eCollection 2018. PubMed PMID: 29868345; PubMed Central PMCID: PMC5984283. Tade FI, Wiles WG 4th, Lu G, Bilir B, Akin-Akintayo O, Lee JS, Patil D, Yu W, Ormenisan Gherasim C, Fei B, Moreno CS, Osunkoya AO, Teoh EJ, Oka S, Okudaira H, Goodman MM, Schuster DM. Selective modification of fluciclovine ((18)F) transport in prostate carcinoma xenografts. Amino Acids. 2018 Jun 15. doi: 10.1007/s00726-018-2600-0. [Epub ahead of print] PubMed PMID: 29905905.